Elizabeth A. Griffiths
0000-0002-0288-8248
Roswell Park Cancer Institute
8 papers found
Refreshing results…
An agenda to advance research in myelodysplastic syndromes: a TOP 10 priority list from the first international workshop in MDS
Safety and efficacy of CPX-351 in younger patients (<60 years old) with secondary acute myeloid leukemia
Consensus proposal for revised International Working Group response criteria for higher risk myelodysplastic syndromes
Finding consistency in classifications of myeloid neoplasms: a perspective on behalf of the International Workshop for Myelodysplastic Syndromes
Prediction of life-threatening and disabling bleeding in patients with AML receiving intensive induction chemotherapy
Mutant PPM1D- and TP53-Driven Hematopoiesis Populates the Hematopoietic Compartment in Response to Peptide Receptor Radionuclide Therapy
Intensive Chemotherapy vs. Hypomethylating Agents in Older Adults with Newly Diagnosed High-Risk Acute Myeloid Leukemia: A Single Center Experience
DNA methyltransferase inhibitors: Class effect or unique agents?
Missing publications? Search for publications with a matching author name.